Safety and Efficacy of EB-001, a Novel Type E Botulinum Toxin, in Subjects with Glabellar Frown Lines: Results of a Phase 2, Randomized, Placebo-Controlled, Ascending-Dose Study - Concepedia

Concepedia

Publication | Closed Access

Safety and Efficacy of EB-001, a Novel Type E Botulinum Toxin, in Subjects with Glabellar Frown Lines: Results of a Phase 2, Randomized, Placebo-Controlled, Ascending-Dose Study

45

Citations

12

References

2018

Year

Steve Yoelin, Sunil Dhawan, Domenico Vitarella, Wajdie Ahmad, Fauad Hasan, Susan Abushakra

Plastic & Reconstructive Surgery

Abstract

Therapeutic, II.

References

	Year	Citations

Page 1